In Reply We thank the authors for their interest in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) studies. We previously reported development of the G-ROP criteria1 and more recently successful validation in a new cohort.2 The authors’ questions pertain to prediction model development. They question parameters for assessing discriminatory performance, which are associated with potential overfitting, and choice of predictive factors, which are associated with potential underfitting.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Binenbaum G, Ying G. Inquiries on the Validation of a Model to Reduce Retinopathy of Prematurity Testing—Reply. JAMA Ophthalmol. Published online April 23, 2020. doi:10.1001/jamaophthalmol.2020.1132
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: